A new agency to take charge of drugs and medicines and food safety will be set up in April by Korea's ministry of health and Welfare.
The agency will be expanded by the end of first-half 1997 to a ministry-level independent agency, provisionally named the National Food and Drug Administration (based on the US FDA), with branches in Seoul, Pusan, Inchon, Taegu, Kwangjiu and Taejon.
Health Minister Kim Yangbae says this development represents the government's "firm determination" to upgrade the quality of life. The NFDA's pharmaceuticals section will absorb certain existing functions and focus on evaluation of medicines, medical equipment and raw and biotechnological preparations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze